Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
Leukemia & Lymphoma|December 3, 2005
Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid massYavuz Beyazit, Ibrahim C Haznedaroglu, Salih Aksu, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 2, 2009
In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarinHandan S Cipil, Ali Kosar, Arif Kaya, et al.Clinics and Research in Hepatology and Gastroenterology|August 2, 2011
Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasmsYavuz Beyazit, Tugrul Purnak, Burak Suvak, et al.Hematology (Amsterdam, Netherlands)|December 18, 2014
Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemiaEylem Eliacik, Ayse Isik, Cisel Aydin, et al.The American Journal of Cardiology|September 5, 2006
Plasma soluble osteopontin concentrations are increased in patients with rheumatic mitral stenosis and associated with the severity of mitral valve calciumEnver Atalar, Ercan Ozturk, Necla Ozer, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 7, 2009
The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding modelAli Kosar, Handan S Cipil, Arif Kaya, et al.Journal of the National Medical Association|February 20, 2007
Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemiaYavuz Beyazit, Salih Aksu, Ibrahim C Haznedaroglu, et al.International Journal of Hematology|February 15, 2002
Plasma thrombopoietin in patients with cavernous transformation of the portal veinHakan Göker, Türker Egesel, Sema Karakuş, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 13, 2008
Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndromeAlpaslan Kilicarslan, Bunyamin Yavuz, Gulay Sain Guven, et al.Journal of the National Medical Association|February 19, 2008
Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesisKadir Acar, Salih Aksu, Yavuz Beyazit, et al.Pageof 11